SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

Share Price is delayed by 15 minutes
Get Live Data
128.80    4.60 (3.70%)
Bid:
128.20
Ask:
129.60
Spread: 1.40 (1.092%)
Market Cap: £536.34m
JHD Live PriceLast checked at - London Stock Exchange

Intraday James Halstead Share Chart

Trading Update

30 Jan 2020 07:00

RNS Number : 2855B
James Halstead PLC
30 January 2020
 

 

 

30 January 2020

 

JAMES HALSTEAD PLCTrading Update

James Halstead plc, the commercial flooring manufacturer and distributor, is providing the following trading update ahead of its interim results for the half-year to 31 December 2019.

 

In his AGM statement, on 6 December 2019, the Chairman, Mr. Anthony Wild, noted that trading to date had been encouraging in terms of turnover and profit for the first five months of the current financial year. This trend continued into December and, once again, the company expects to attain record turnover for the half-year. The projects supplied continue to span the globe with interesting examples such as the Hobbiton tourist resort in New Zealand and Agent Provocateur in London together with the ubiquitous supply of flooring to the NHS such as Chelsea & Westminster Hospital and Hull Royal Infirmary.

 

Turnover in the UK was 6.8% ahead of the prior year, a creditable performance against the prevailing market conditions. Underlying margins held up but in the period July through to September there were adverse manufacturing variances and incremental labour costs associated with extended shifts / overtime subsequent to a significant engineering breakdown. Notwithstanding this adversity the company expects to report record pre-tax profit for the half-year.

 

Our balance sheet remains robust.

 

Interim results will be published on 31 March 2020.

 

Enquiries:

James Halstead plc

Tel: 0161 767 2500

Mark Halstead, Chief Executive

Gordon Oliver, Finance Director

Hudson Sandler

Tel: 020 7796 4133

Nick Lyon /Nick Moore

Panmure Gordon (Nomad and Joint Broker)

Tel: 020 7886 2500

Dominic Morley

Arden Partners (Joint Broker)

Richard Johnson

 

Tel: 020 7614 5900

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKCBBCBKKKDB
Date   Source Headline
6th Dec 20198:30 amRNSAGM Statement
18th Oct 20199:51 amRNSNotice of Results
1st Oct 20197:00 amRNSPreliminary Results
18th Sep 20197:00 amRNSNotice of Preliminary Results
23rd Aug 20194:37 pmRNSPrice Monitoring Extension
30th Jul 20197:00 amRNSPre-Close Trading Statement
3rd Jul 20194:41 pmRNSNew Corporate Website
3rd Jun 201910:31 amRNSTotal Voting Rights
15th May 20198:08 amRNSDirector/PDMR Shareholding
10th May 20192:36 pmRNSDirector/PDMR Shareholding
3rd May 20192:07 pmRNSTotal Voting Rights
2nd Apr 20199:57 amRNSBlock listing Interim Review
1st Apr 20196:19 pmRNSTotal Voting Rights
29th Mar 20197:00 amRNSInterim Results
28th Mar 20191:24 pmRNSNotice of Interim Results - Update
25th Mar 20199:35 amRNSNotice of Interim Results
30th Jan 20197:00 amRNSPre Close Trading Statement
28th Jan 20191:16 pmRNSDirector/PDMR Shareholding
7th Dec 20184:13 pmRNSResult of AGM
7th Dec 20187:00 amRNSAGM Statement
19th Oct 20184:02 pmRNSAnnual Financial Report and Notice of AGM
19th Oct 20187:00 amRNSDirector/PDMR Shareholding
18th Oct 20187:00 amRNSAdditional Listing
18th Oct 20187:00 amRNSTotal Voting Rights
16th Oct 20186:13 pmRNSBlock listing Interim Review
27th Sep 20184:48 pmRNSDirector/PDMR Shareholding
26th Sep 20187:00 amRNSPreliminary Results
17th Sep 20187:00 amRNSNotice of Preliminary Results
25th Jul 20187:00 amRNSPre-Close Trading Statement
22nd May 20184:58 pmRNSRule 2.8 Announcement
22nd May 20189:39 amRNSForm 8.5 (EPT/RI) - James Halstead PLC
21st May 20189:46 amRNSForm 8.3 - James Halstead
18th May 20182:52 pmRNSForm 8.3 - James Halstead
18th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
17th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
17th May 20187:57 amRNSForm 8.5 (EPT/RI) - James Halstead PLC
16th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
15th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
14th May 201811:57 amRNSForm 8.5 (EPT/NON-RI)
11th May 20183:26 pmRNSDirector/PDMR Shareholding
11th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
11th May 201810:20 amRNSForm 8.3 - James Halstead
11th May 20189:07 amRNSForm 8.5 (EPT/RI) - James Halstead PLC
10th May 20181:36 pmRNSDirector/PDMR Shareholding
10th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
10th May 20189:12 amRNSForm 8.3 - James Halstead
9th May 20183:29 pmBUSForm 8.3 - James Halstead PLC
9th May 201811:57 amRNSForm 8.5 (EPT/RI) - James Halstead PLC
9th May 201811:57 amRNSForm 8.5 (EPT/NON-RI)
8th May 20181:22 pmRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.